PATENT CLAIM ANALYSIS

Application Number: 15913792
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "279000"]

Abstract:
An abuse deterrent opioid formulation for rectal use. The formulation contains a therapeutically effective amount of the opioid buprenorphine or salts and homologs thereof; and either a gel with a diminishing agent or a suppository base with a diminishing agent into which the opioid buprenorphine is mixed.

Claim (Index 20):
The abuse deterrent opioid formulation for rectal use of  claim 19 , wherein the syringe has plunger and a rectal injection tip for injection of the opioid formulation into a patient's rectum.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 90.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12597702', '13926206', '12965572', '14339143', '12383906']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7956289483418199
- 35 USC 102 Novelty (BERT): 0.5212597911975952
- Combined Prediction Score: 0.7681920326273974
- Mean Citation Score: 258.38171600000004
- Max Citation Score: 277.38162
- Similarity Product: 159.72850570513845

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test